Brief: Cynata Therapeutics Posts HY Loss From Ordinary Activities After Tax Attributable A$4.5 Mln
23/02/2024 06:14
Feb 23 (Reuters) - Cynata Therapeutics Ltd CYP.AX :
* HY LOSS FROM ORDINARY ACTIVITIES AFTER TAX ATTRIBUTABLE
A$4.5
MILLION VERSUS LOSS A$5.2 MILLION
* HY REVENUE AND OTHER INCOME A$2.5 MILLION VERSUS A$1.8
MILLION
Source text for Eikon: ID:nASX9f0My
Further company coverage: CYP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cynata Therapeutics
See all newsBrief: Cynata Therapeutics Says Firm Commitments Received To Raise Further A$550,000 Via Placement
Brief: Cynata Therapeutics Enters Consultancy Agreement With LIR Bio Advisory
Brief: Cynata Therapeutics Establishes Share Sale Facility For Unmarketable Parcel Holders
Brief: Cynata Therapeutics Terminates Of At-The-Market Subscription Deed
Brief: Cynata Therapeutics Posts FY2026 Loss From Ordinary Activities After Tax A$9.1 Million